Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyClinical Trials(32 courses)
All specialties

Clinical Trials

32 courses

2026 CCC | Role of Pharmacokinetics in Early Phase Clinical Trials

2026 CCC | Role of Pharmacokinetics in Early Phase Clinical Trials

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | ctDNA in Clinical Trial Development

2026 CCC | ctDNA in Clinical Trial Development

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | A Phase 0/I Trial Combining Triapine with Radiation Therapy for Recurrent Glioblastoma

2026 CCC | A Phase 0/I Trial Combining Triapine with Radiation Therapy for Recurrent Glioblastoma

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients w/ Advanced NSCLC (NCI 10327): Rationale & Study Design

2026 CCC | Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients w/ Advanced NSCLC (NCI 10327): Rationale & Study Design

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | Phase 2 Study of Ipatasertib in Combination w/ Pembrolizumab for 1st-line Treatment of Recurrent or Metastatic Squamous Cell Cancer

2026 CCC | Phase 2 Study of Ipatasertib in Combination w/ Pembrolizumab for 1st-line Treatment of Recurrent or Metastatic Squamous Cell Cancer

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma

2026 CCC | A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | A Phase 1B Study of AMG-232 in Combination with Decitabine and Venetoclax in Acute Myeloid Leukemia

2026 CCC | A Phase 1B Study of AMG-232 in Combination with Decitabine and Venetoclax in Acute Myeloid Leukemia

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | A Phase 1 Study of M3814 in Combination with MEC in Patients with Relapsed or Refractory Acute Myeloid Leukemia

2026 CCC | A Phase 1 Study of M3814 in Combination with MEC in Patients with Relapsed or Refractory Acute Myeloid Leukemia

0.00 Credits
1 Chapter
Clinical Trials
Free
2026 CCC | Optimizing Early Phase Trial Designs

2026 CCC | Optimizing Early Phase Trial Designs

0.00 Credits
1 Chapter
Clinical Trials
Free
2025 CCC | Optimizing Early Phase Trial Designs

2025 CCC | Optimizing Early Phase Trial Designs

0.00 Credits
1 Chapter
Clinical Trials
Free
Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

0.00 Credits
1 Chapter
Clinical Trials
Free
Phase 1 Trials What’s New in 2019

Phase 1 Trials What’s New in 2019

0.00 Credits
1 Chapter
Clinical Trials
Free
Translating Clinical Trials' Results into Clinical Practice

Translating Clinical Trials' Results into Clinical Practice

0.00 Credits
1 Chapter
Clinical Trials
Free
Integrating Biomarkers into Targeted Therapy and Immunotherapy Clinical Trials

Integrating Biomarkers into Targeted Therapy and Immunotherapy Clinical Trials

0.00 Credits
1 Chapter
Clinical Trials
Free
Phase I Trials: Whats New in 2019?

Phase I Trials: Whats New in 2019?

0.00 Credits
1 Chapter
Clinical Trials
Free
From Bench to Bedside (and Back): Early Clinical Trials

From Bench to Bedside (and Back): Early Clinical Trials

0.00 Credits
1 Chapter
Clinical Trials
Free
Panel_ Translating Clinical Trials' Results into Clinical Practice

Panel_ Translating Clinical Trials' Results into Clinical Practice

0.00 Credits
1 Chapter
Clinical Trials
Free
A Vision for Optimizing Patient Outcomes

A Vision for Optimizing Patient Outcomes

0.00 Credits
1 Chapter
Clinical Trials
Free
Understanding Multi-Cohort Trials

Understanding Multi-Cohort Trials

0.00 Credits
1 Chapter
Clinical Trials
Free
Clinical Trials 101

Clinical Trials 101

0.00 Credits
1 Chapter
Clinical Trials
Free
Phase 1 Exp Cohorts vs Phase 2 Trials

Phase 1 Exp Cohorts vs Phase 2 Trials

0.00 Credits
1 Chapter
Clinical Trials
Free
Modern Clinical Trial Design, Pharmacology and Drug Development

Modern Clinical Trial Design, Pharmacology and Drug Development

0.00 Credits
1 Chapter
Clinical Trials
Free
Innovative Early Phase Clinical Trial Designs

Innovative Early Phase Clinical Trial Designs

0.00 Credits
1 Chapter
Clinical Trials
Free
Current Epidemiology and Incidence of Esophageal Cancer: East vs West; Implications on Clinical Trials

Current Epidemiology and Incidence of Esophageal Cancer: East vs West; Implications on Clinical Trials

0.00 Credits
1 Chapter
Clinical Trials
Free
Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

0.00 Credits
1 Chapter
Clinical Trials
Free
Showing 25 of 32 courses

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure